DGX:NYSE
Quest Diagnostics Inc
$232.63
0.00%
(0.00) 1D
Oct 12, 4:00:03 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DGX...
Mkt. cap
25.68B
Avg. vol.
1.12M
Volume
16.00
Dividend
1.48%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
24.73
52-wk high
$248.84
52-wk low
$171.18
EPS
$9.41
Beta
0.54
Shares outstanding
110.37M
No. of employees
52K
Mkt. cap
25.68B
Avg. vol.
1.12M
Volume
16.00
Dividend
1.48%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
24.73
52-wk high
$248.84
52-wk low
$171.18
EPS
$9.41
Beta
0.54
Shares outstanding
110.37M
No. of employees
52K
News stories
From web sources and news partners
National Hog Farmer
·
34 minutes ago
NYSE owner plans futures for livestock in a bid to challenge CME Group
Business Wire
·
1 hour ago
Powerus (Nasdaq: PUSA) Unveils Fully Autonomous Drone Interceptors at AUSA 2026
GlobeNewswire
·
47 minutes ago
Primech Holdings (Nasdaq: PMEC) to Present at LD Micro Main
Profile
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
About Quest Diagnostics Inc
CEOJames E. Davis
Employees51.5K
Founded1967
Headquarters-
SectorHealth care provider
Websitequestdiagnostics.com